C1739 HCPCS Level II code: Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system
C1739 is the HCPCS code for “Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
C1739Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system
Short description: Marker uniq detect w/prbe
HCPCS · United States
Medicare details
The indicators CMS publishes with C1739 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Other medical items or services
- BETOS category
- Medical/surgical supplies
- Coverage statute
- 1833(t)
- Added
- Jan 1, 2025
Where C1739 sits
- 1C codesOutpatient prospective payment system
- 2Active code C1739Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code C1739 mean?
C1739 is the HCPCS code for “Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover C1739?
CMS lists C1739’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C1739
All C codesC1733Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tipC1734Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)C1735Catheter(s), intravascular for renal denervation, radiofrequency, including all single use system componentsC1736Catheter(s), intravascular for renal denervation, ultrasound, including all single use system componentsC1737Joint fusion and fixation device(s), sacroiliac and pelvis, including all system components (implantable)C1738Powered, single-use (i.e. disposable) endoscopic ultrasound-guided biopsy deviceC1740Leadless electrode, transmitter, battery (all implantable), for sequential left ventricular pacingC1741Anchor/screw for bone fixation, absorbable, metallic (implantable)C1742Pressure monitoring system, compartmental intramuscular (implantable), continuous, including all components (e.g., introducer, sensor), excludes mobile (wireless) software…C1743Scaffold, endovascular non-coronary, resorbable drug eluting, with delivery system (implantable)C1747Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable)C1748Endoscope, single-use (i.e. disposable), upper gi, imaging/illumination device (insertable)